Tevogen Bio (TVGN)
Develops ExacTcell-based T-cell therapy candidates for COVID-19, cancer and Long COVID.
$6.92
Pre-market−0.25 (−3.49%)
At close$7.17(0.00%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions29 holders · as of Mar 31, 2026 | 3.26% | 135.8K shares | |
| Insiders9 holders · as of Jul 14, 2026 | 103.80% | 4.32M shares | |
| Adds to | 107.06% |
4.16M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (6.51M in the company's Sep 3, 2026 report, 4.16M elsewhere); stakes use the report.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
These groups come from separate filings that can overlap, so they add to 107.06%; nothing is left for Other.
Institutions13F, as of Mar 31, 2026
29 holders · 135.8K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 33.2K | 0.80% | May 15, 2026 | |
| BlackRock, Inc. | 24.4K | 0.59% | May 13, 2026 | |
| Morgan Stanley | 17.3K | 0.42% | May 15, 2026 | |
| Geode Capital Management, LLC | 15.7K | 0.38% | May 15, 2026 | |
| Deutsche Bank AG\ | 15.3K | 0.37% | May 6, 2026 | |
| FMR LLC | 10.2K | 0.24% | May 15, 2026 | |
| Russell Investments Group, Ltd. | 5.8K | 0.14% | May 8, 2026 | |
| Vanguard Portfolio Management LLC | 4.5K | 0.11% | May 8, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Ryan H. Saadi | 62.00% | 13D | Dec 16, 2025 ↗ | |
| Saadi Ryan H. | 59.70% | 3.71M | 13D | Jul 14, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 13, 2026 | Neal Flomenbergofficer: See Remarks | Sale | 501 | $6.40 | 76,940 |
| Mar 11, 2026 | Neal Flomenbergofficer: See Remarks | Sale | 452 | $7.26 | 77,441 |
| Mar 10, 2026 | Neal Flomenbergofficer: See Remarks | Sale | 19 | $7.75 | 77,893 |
CongressHouse and Senate disclosures
Not reported.
